Shao YF, Echegaray JJ, Singh AD. Metastatic Tumors of the Uvea. Intraocular Tumors 179–185 (Springer Singapore, 2019)
Kanayama M., Colomba E., Shao Y., Nielsen S.M., Esplin E.D., Lu C., Isaacs W.B., Henegan J.C., Heath E.I., Luo J., Marlin R., and Antonarakis E.S. A case series explores hormonal sensitivity in prostate cancer patients with the germline African-ancestry HOXB13 X285K variant. Prostate Cancer and Prostatic Diseases. Published June 21, 2025. DOI: 10.1038/s41391-025-00994-5. PMID: 40542273.
Shao Y.F., Baca Y., Hinton A., Xiu J., VanderWalde A., Hadfield M., Park S.J., Darabi S., Sato T., and Moser J.C. Immune profiling of uveal melanoma liver metastases and response to checkpoint inhibitors. Journal of Immunotherapy. June 1, 2025; Vol. 48, No. 5, pp. 189–195. DOI: 10.1097/CJI.0000000000000558. PMID: 40231356.
Khan F.H., Reza M.J., Shao Y.F., Perwez A., Zahra H., Dowlati A., and Abbas A. A comprehensive look at exosomes in lung cancer, from immunomodulation to theragnostic applications. Biochimica et Biophysica Acta Reviews on Cancer. September 2022; Vol. 1877, Issue 5: Article 188776. DOI: 10.1016/j.bbcan.2022.188776. PMID: 35961620.
Shao Y.F., DeBenedictis M., Yeaney G., and Singh A.D. Study links germline BAP1 mutation with uveal melanoma and renal cell carcinoma. Ocular Oncology and Pathology. October 2021; Vol. 7, No. 5, pp. 340–345. DOI: 10.1159/000516695. PMID: 34722490.
Shao Y.F., Echegaray J.J., Singh N., and Singh A.D. Examining variability in prognosis of uveal melanoma. Ophthalmology Retina. February 2019; Vol. 3, No. 2, pp. 186–193. DOI: 10.1016/j.oret.2018.09.007. PMID: 31014770.
Brewington B.Y., Shao Y.F., Davidorf F.H., and Cebulla C.M. Brachytherapy in uveal melanoma: a historical and future-focused review. Clinical Ophthalmology. May 17, 2018; Vol. 12, pp. 925–934. DOI: 10.2147/OPTH.S129645. PMID: 29844657